0069-0342 : Zirabev 400 mg/16ml Intravenous Injection, Solution
NDC: | 0069-0342 |
Labeler: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Zirabev |
Dosage Form: | Intravenous Injection, Solution |
Application #: | BLA761099 |
Rev. Date: |
NDC Package Codes:
- 0069-0342-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (0069‑0342‑01) > 16 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Bevacizumab
Dosage Strength:
- 400 mg/16mL
Pharmaceutical Classes:
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
- Vascular Endothelial Growth Factor Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0069-0315 Zirabev 100 mg/4ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0069-0338Next: 0069-0344 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.